Showing results (1391-1400 of 1,943) with videos related to
Sort By:
Pageof 195
Life Sciences|October 9, 2020
Neuronal and non-neuronal transient receptor potential ankyrin 1 mediates UVB radiation-induced skin inflammation in miceCamila Camponogara, Evelyne S Brum, Natháli S Pegoraro, et al.The FEBS Journal|March 8, 2019
Antibacterial action of synthetic antilipopolysaccharide peptides (SALP) involves neutralization of both membrane-bound and free toxinsWilmar Correa, Lena Heinbockel, Jochen Behrends, et al.Journal of Clinical Medicine|December 23, 2023
X-Linked Hypophosphatemia: Does Targeted Therapy Modify Dental Impairment?Anusha Abdullah, Sabina Noreen Wuersching, Maximilian Kollmuss, et al.Dento Maxillo Facial Radiology|July 10, 2023
Automated detection of cephalometric landmarks using deep neural patchworksJulia Vera Weingart, Stefan Schlager, Marc Christian Metzger, et al.Science (New York, N.Y.)|March 15, 2003
Loss of IGF2 imprinting: a potential marker of colorectal cancer riskHengmi Cui, Marcia Cruz-Correa, Francis M Giardiello, et al.The EMBO Journal|January 5, 2022
Pharmacological CDK4/6 inhibition reveals a p53-dependent senescent state with restricted toxicityBoshi Wang, Marta Varela-Eirin, Simone M Brandenburg, et al.Annals of the Rheumatic Diseases|December 22, 2010
Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout miceChristoph Jan Wruck, Athanassios Fragoulis, Agata Gurzynski, et al.Physical Review Letters|September 16, 2000
Study of exclusive radiative B meson decaysBrandenburg, Ershov, Gao, et al.Acta Neuropathologica|March 18, 2008
Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's diseaseLuigi Zecca, Henrik Wilms, Sebastian Geick, et al.Pharmaceutics|November 26, 2022
Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous LeishmaniasisRima El-Dirany, Celia Fernández-Rubio, José Peña-Guerrero, et al.Pageof 195